Skip to content
Screener

HealthEquity HQY Investing Cash Flow

Investing Cash Flow at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
-$2.45B-3,207%
Webster Financial Corporation logo
Webster Financial CorporationWBS
-$552.94M+49.2%
Willis Towers Watson logo
Willis Towers WatsonWTW
-$336M-148%
WEX logo
WEXWEX
-$255.9M+34.8%
Voya Financial logo
Voya FinancialVOYA
$724M+238%
CVS Health logo
CVS HealthCVS
-$1.88B-84.0%

Other financials

Income statement

See full
Revenue$354.6M+7.2%
Gross profit$256.3M+14.3%
Operating income$103.0M+23.9%
Net income$69.4M+28.8%
EPS (diluted)$0.82+34.4%

Balance sheet

See full
Cash & equivalents$265.4M-7.8%
Total debt$984.7M-11.0%
Total equity$2.0B-3.6%
Total assets$3.3B-3.2%

Cash flow

See full
Operating cash flow$97.5M+50.6%
CapEx$362.0K+321%
Free cash flow$97.2M+50.3%

Valuation

See full
Market cap$8.73B+11.0%
Enterprise value$9.45B+9.7%
P/E37.8×-16.1×
P/S6.5×+0.3×

Profitability

See full
Gross margin70.7%+5.2pp
Operating margin25.6%+9.2pp
Net margin17.3%+7.5pp
FCF margin36.5%+9.3pp

Returns & leverage

See full
Return on equity11.1%+5.3pp
Debt / equity0.5×0.0×
Current ratio3.4×-0.6×

Where this comes from

Reported directly by HealthEquity in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: HealthEquity’s 10-Q, filed May 28, 2026.

Filed
May 28, 2026, 4:04 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001428336-26-000028
(in thousands)Three months ended April 30, 2026Three months ended April 30, 2025
Purchases of software and capitalized software development costs(15,930)(16,057)
Purchases of property and equipment(362)(86)
Settlement of derivatives, net2,388
Net cash used in investing activities(13,904)(16,143)
Cash flows from financing activities:
Repurchases of common stock(123,314)(59,065)
Principal payments on long-term debt(15,000)
Settlement of client-held funds obligation, net7161,451

Item 1. Financial statements

FAQ

What is HealthEquity's investing cash flow?
HealthEquity (HQY) reported investing cash flow of -$13.9M in Q1 2026.
How has HealthEquity's investing cash flow changed year-over-year?
HealthEquity's investing cash flow increased by 13.9% year-over-year, from -$16.14M to -$13.9M.
What is the long-term trend for HealthEquity's investing cash flow?
Over 4 years (2022 to 2026), HealthEquity's investing cash flow has grown at a -47.9% compound annual growth rate (CAGR), from -$639.25M to -$47.14M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about HealthEquity's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude